Elarex
Burlington
About Elarex
Elarex is a Canadian healthcare technology company commercializing its proprietary PT120 formulation technology which has proven to stabilize biologicals (including live vaccines!) so that they are as effective when stored at 40C as if they had been stored at -80C.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Total funding: $943.0K
- Last round: Grant (Dec 2021)
- Website: elarexinc.com
- Phone: [email protected]
Industries & Categories
Biotechnology, Health Care, Medical
Social Profiles
Canonical: https://fsome.com/organization/elarex-111594 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.